O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
+15.41%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$5.46B
AUM Growth
+$5.46B
(+8.6%)
Cap. Flow
-$50.4M
Cap. Flow
% of AUM
-0.92%
Top 10 Holdings %
Top 10 Hldgs %
41.94%
Holding
129
New
17
Increased
19
Reduced
31
Closed
16
Top Buys
| 1 |
MBX
MBX Biosciences, Inc. Common Stock
MBX
|
$99M |
| 2 |
UnitedHealth
UNH
|
$39.2M |
| 3 |
Sarepta Therapeutics
SRPT
|
$38.5M |
| 4 |
Amgen
AMGN
|
$37.8M |
| 5 |
Universal Health Services
UHS
|
$35.7M |
Top Sells
| 1 |
Janux Therapeutics
JANX
|
$78.2M |
| 2 |
Tenet Healthcare
THC
|
$65M |
| 3 |
Vaxcyte
PCVX
|
$46.7M |
| 4 |
VRNA
Verona Pharma
VRNA
|
$41.4M |
| 5 |
Geron
GERN
|
$37.9M |
Sector Composition
| 1 | Healthcare | 99.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Solventum
SOLV
$12.4B
| – | – |
0
| – | – |
|
|
MORF
127
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| – | – |
-612,500
| Closed | -$20.9M |
|
|
OMIC
128
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
| – | – |
-18,023
| Closed | -$152K |
|